# Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

> **NCT00331838** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 705 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Semuloparin sodium
- **DRUG:** Placebo (for Enoxaparin sodium)
- **DRUG:** Enoxaparin sodium
- **DRUG:** Placebo (for Semuloparin sodium)

## Key facts

- **NCT ID:** NCT00331838
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 705 (ACTUAL)
- **Last updated:** 2013-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331838, "Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00331838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*